Search...
Features
Assets
Blog
Help
Learn
Get App
Login
Sign Up
Get App
Prelude Therapeutics (PRLD) Q3 2023 Earnings
PRLD
1
Nov
Confirmed
Q4 2022
Q1 2023
Q2 2023
Q3 2023
-0.68
-0.6
-0.53
-0.45
Details
Expected EPS
-0.58
Actual EPS
-0.45
Surprise EPS
0.13
Surprise Percent
+22.41%
Description
Prelude Therapeutics (PRLD) has reported earnings of -0.45 per share for Q3 2023.
0 Comments
Share your thoughts
Get the Stock Events App
Sign up for a Stock Events account to create your own watchlists and track your portfolio or dividends.
Sign Up
Login